Integrative Molecular Profiling and Single-Cell Characterization of LHFPL5 Reveal Cancer-Specific Regulatory Features in Clear Cell Renal Cell Carcinoma and Lung Adenocarcinoma
- 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, , Madinah 42353, Saudi Arabia;
Abstract
Background and Objectives: LHFPL5 encodes a four-pass transmembrane protein essential for cochlear mechanotransduction, but its molecular behavior in cancer remains poorly defined. We characterized the genomic, epigenetic, transcriptomic, immune, and cellular context of LHFPL5 in clear cell renal cell carcinoma (KIRC) and lung adenocarcinoma (LUAD), along with its associations with clinical outcomes. Materials and Methods: Retrospective analyses integrated TCGA RNA sequencing, clinical, DNA methylation, copy number, tumor purity, and immune deconvolution data. Transcriptome-wide associations and Hallmark enrichment defined LHFPL5-associated programs. Continuous-expression Cox models estimated hazard ratios (HRs) per standard-deviation increase, adjusted for age, sex, and pathological stage. GEO cohorts assessed external reproducibility, matched TCGA expression pipelines assessed processing sensitivity, and three non-TCGA single-cell datasets examined cellular localization. Results: LHFPL5 showed distinct molecular contexts in KIRC and LUAD. In KIRC, higher expression remained associated with poorer overall survival after clinical adjustment (528 patients; 174 deaths; HR = 1.36, 95% CI 1.21–1.53; p = 2.42 × 10⁻⁷), while subtype and immune fractions showed limited statistical overlap with the association. In LUAD, expression covaried with copy-number state and showed a weak inverse relationship with first-exon methylation. Proliferation-related transcriptional programs were associated with survival, although enrichment support depended on the multiple-testing procedure. The primary STAR-derived LUAD analysis was null (485 patients; 177 deaths; HR = 1.02, 95% CI 0.89–1.18; p = 0.770), and survival inference varied with RNA processing. External adjusted replication was inconclusive. Single-cell detection was sparse in KIRC and one LUAD dataset; another LUAD cohort showed more frequent epithelial detection without resolved malignant-cell identity. Conclusions: LHFPL5 exhibits cancer-specific molecular architecture. LUAD showed copy-number, methylation, and proliferation-related associations, whereas KIRC showed a distinct molecular context with an independent survival signal. These findings support context-dependent LHFPL5 regulation and prioritize genomic, epigenetic, and transcriptional mechanisms for functional investigation.
Related
- Integrative Phosphoproteomic Characterization of ULK1 Phosphosites Reveals Co-Regulatory Networks in Autophagy and Metabolic Adaptation
- Synchronous Small Cell and Adenocarcinoma of the Lung Integrating Morphology and Molecular Profiling: A Case Report
- Coordinated upregulation of Hippo, NF-κB and interferon pathway genes in pancreatic ductal adenocarcinoma: a retrospective tissue qRT-PCR profiling study with external tumour-versus-non-tumour validation, molecular subtype and survival analyses.
- An entosis-informed prognostic index for survival stratification and molecular characterization in lung adenocarcinoma.
- An Oxidative Stress-Associated Seven-Gene Prognostic Signature in Lung Adenocarcinoma: Integrative Transcriptomic Analysis Across Public Cohorts
BibTeX
@article{alnakhle2026integrative,
title = {{Integrative Molecular Profiling and Single-Cell Characterization of LHFPL5 Reveal Cancer-Specific Regulatory Features in Clear Cell Renal Cell Carcinoma and Lung Adenocarcinoma}},
author = {Hakeemah H. Al-Nakhle and Zinab O. Doha},
journal = {Medicina (Kaunas, Lithuania)},
year = {2026},
month = oct,
doi = {10.3390/medicina62101971},
url = {https://europepmc.org/article/PMC/PMC13706886},
note = {CC BY},
}
RIS
TY - JOUR
TI - Integrative Molecular Profiling and Single-Cell Characterization of LHFPL5 Reveal Cancer-Specific Regulatory Features in Clear Cell Renal Cell Carcinoma and Lung Adenocarcinoma
AU - Hakeemah H. Al-Nakhle
AU - Zinab O. Doha
PY - 2026
DA - 2026/10/01
JO - Medicina (Kaunas, Lithuania)
DO - 10.3390/medicina62101971
UR - https://europepmc.org/article/PMC/PMC13706886
AB - Background and Objectives: LHFPL5 encodes a four-pass transmembrane protein essential for cochlear mechanotransduction, but its molecular behavior in cancer remains poorly defined. We characterized the genomic, epigenetic, transcriptomic, immune, and cellular context of LHFPL5 in clear cell renal cell carcinoma (KIRC) and lung adenocarcinoma (LUAD), along with its associations with clinical outcomes. Materials and Methods: Retrospective analyses integrated TCGA RNA sequencing, clinical, DNA methylation, copy number, tumor purity, and immune deconvolution data. Transcriptome-wide associations and Hallmark enrichment defined LHFPL5-associated programs. Continuous-expression Cox models estimated hazard ratios (HRs) per standard-deviation increase, adjusted for age, sex, and pathological stage. GEO cohorts assessed external reproducibility, matched TCGA expression pipelines assessed processing sensitivity, and three non-TCGA single-cell datasets examined cellular localization. Results: LHFPL5 showed distinct molecular contexts in KIRC and LUAD. In KIRC, higher expression remained associated with poorer overall survival after clinical adjustment (528 patients; 174 deaths; HR = 1.36, 95% CI 1.21–1.53; p = 2.42 × 10⁻⁷), while subtype and immune fractions showed limited statistical overlap with the association. In LUAD, expression covaried with copy-number state and showed a weak inverse relationship with first-exon methylation. Proliferation-related transcriptional programs were associated with survival, although enrichment support depended on the multiple-testing procedure. The primary STAR-derived LUAD analysis was null (485 patients; 177 deaths; HR = 1.02, 95% CI 0.89–1.18; p = 0.770), and survival inference varied with RNA processing. External adjusted replication was inconclusive. Single-cell detection was sparse in KIRC and one LUAD dataset; another LUAD cohort showed more frequent epithelial detection without resolved malignant-cell identity. Conclusions: LHFPL5 exhibits cancer-specific molecular architecture. LUAD showed copy-number, methylation, and proliferation-related associations, whereas KIRC showed a distinct molecular context with an independent survival signal. These findings support context-dependent LHFPL5 regulation and prioritize genomic, epigenetic, and transcriptional mechanisms for functional investigation.
SN - 1010-660X
SN - 1648-9144
ER -